{"id":496598,"date":"2026-01-06T13:50:10","date_gmt":"2026-01-06T13:50:10","guid":{"rendered":"https:\/\/www.europesays.com\/us\/496598\/"},"modified":"2026-01-06T13:50:10","modified_gmt":"2026-01-06T13:50:10","slug":"japanese-startups-tout-chatbot-powered-apps-as-treatment-for-medical-conditions","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/496598\/","title":{"rendered":"Japanese startups tout chatbot-powered apps as treatment for medical conditions"},"content":{"rendered":"<p>Japan\u2019s medical industry has generally been slow to embrace digital technology, with many clinics still keeping patient records and writing prescriptions on paper.<\/p>\n<p>But a few domestic startups have recently launched chatbot-powered apps designed to help treat a range of conditions, such as hypertension, alcohol addiction and insomnia. Unlike the plethora of lifestyle apps anyone with a smartphone can download, these are prescription-only medical apps whose efficacy has been demonstrated in clinical trials.<\/p>\n<p>For Taro Ueno, a psychiatrist and brain researcher, the idea to develop an app for insomnia came from observing how doctors in Japan overprescribe sleeping pills.<\/p>\n","protected":false},"excerpt":{"rendered":"Japan\u2019s medical industry has generally been slow to embrace digital technology, with many clinics still keeping patient records&hellip;\n","protected":false},"author":3,"featured_media":496599,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17],"tags":[9470,16028,210,1184,611,158,67,132,68],"class_list":{"0":"post-496598","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-mobile","8":"tag-apps","9":"tag-chatbots","10":"tag-health","11":"tag-medicine","12":"tag-mobile","13":"tag-technology","14":"tag-united-states","15":"tag-unitedstates","16":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115848480208601257","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/496598","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=496598"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/496598\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/496599"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=496598"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=496598"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=496598"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}